Hyperandrogenemia in male autistic children and adolescents: Relation to disease severity

International Journal of Adolescent Medicine and Health

Volumn 26, Issue 1, 2014, Pages 79-84

  El Baz, Farida ^b   Hamza, Rasha T ^a,b   Ayad, Mohamed S E ^b   Mahmoud, Nermine H ^b  

^a Ain Shams University ^*  (Egypt)

^b AIN SHAMS UNIVERSITY   (Egypt)

Author keywords

Adolescents; Autism; Children; Hyperandrogenemia; Severity

Indexed keywords

ANDROGEN; ANDROSTENEDIONE; PRASTERONE; TESTOSTERONE;

ADOLESCENT; ADOLESCENT DISEASE; AGE; ANDROGEN BLOOD LEVEL; ANDROSTENEDIONE BLOOD LEVEL; ARTICLE; AUTISM; CASE CONTROL STUDY; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; EGYPTIAN; HUMAN; HYPERANDROGENISM; INTELLIGENCE QUOTIENT; MALE; PRECOCIOUS PUBERTY; RISK FACTOR; TESTOSTERONE BLOOD LEVEL; BLOOD; EGYPT; INTELLIGENCE; SEVERITY OF ILLNESS INDEX;

ADOLESCENT; ANDROGENS; ANDROSTENEDIONE; AUTISTIC DISORDER; CHILD; CROSS-SECTIONAL STUDIES; DEHYDROEPIANDROSTERONE; EGYPT; HUMANS; INTELLIGENCE; MALE; SEVERITY OF ILLNESS INDEX; TESTOSTERONE;

EID: 84901712437     PISSN: 03340139     EISSN: 21910278     Source Type: Journal    
DOI: 10.1515/ijamh-2012-0116     Document Type: Article

References (35)

1. Arndt TL, Stodgell CJ, Rodier PM. The teratology of autism. Int J Dev Neurosci 2005;23:189-99.
2. Bailey A, Luthert P, Dean A, Harding B, Janota I, et al. Clinicopathological study of autism. Brain 1998;121:889-905.
3. Baron-Cohen S, Knickmeyer R, Belmonte MK. Sex differences in the brain: implications for explaining autism. Science 2005;310:819-23.
4. th digit ratios, fetal testosterone and estradiol. Early Hum Dev 2004;77:23-8.
5. Herbert MR, Ziegler DA, Deutsch CK, O'Brien LM, Kennedy DN, et al. Brain asymmetries in autism and developmental language disorder: a nested whole-brain analysis. Brain 2005;128:213-26.
6. Knickmeyer RC, Fane BA, Mathews G, Wheelwright S, Baron-Cohen S, et al. Autistic traits in people with congenital adrenal hyperplasia: a test of the fetal testosterone theory of autism. Horm Behav 2006;50:148-53.
7. Ingudomnukul E, Baron-Cohen S, Wheelwright S, Knickmeyer R. Elevated rates of testosterone related disorders in women with autism spectrum conditions. Horm Behav 2007;51:597-604.
8. Geier DA, Geier MR. A prospective assessment of androgen levels in patients with autistic spectrum disorders: biochemical underpinnings and suggested therapies. Neuro Endocrinol Lett 2007;28:565-73.
9. th ed. Washington, DC: American Psychiatric Association, 1994.
10. Schopler E, Reichler RJ, Renner BR. The childhood autism rating scale (CARS) for diagnostic screening and classification in autism. New York: Irvington, 1986.
11. rd Revision Form L-M. Chicago: The Riverside Publishing Company, 1973.
12. Tanner JM, Whitehouse RH, Takaishi M. Standards from birth to maturity for height, weight, height velocity and weight velocity: British children, 1965. Arch Dis Child 1966;41:454-613.
13. Tanner JM, Whitehouse RH. Clinical longitudinal standards for height, weight, height velocity, weight velocity and stages of puberty. Arch Dis Child 1976;51:170-9.
14. Prader A. Testicular size: assessment and clinical importance. Triangle 1966;7:240-3.
15. Ankarberg-Lindgren C, Norjavaara E. Changes of diurnal rhythm and levels of total and free testosterone secretion from pre to late puberty in boys: testis size of 3 ml is a transition stage to puberty. Eur J Endocrinol 2004;151:747-57.
16. Lashansky G, Saenger P, Fishman K. Normative data for adrenal steroidogenesis in a healthy pediatric population: age- and sex-related changes after adrenocorticotropin stimulation. J Clin Endocrinol Metab 1991;73:674-86.
17. Tordjman S, Ferrari P, Sulmont V, Duyme M, Roubertoux P. Androgenic activity in autism. Am J Psychiatry 1997;154:1626-27.
18. Majewska MD, Hill M, Urbanowicz E, Rok-Bojko P, Namyslowska I, et al. Different levels of salivary steroids in autistic and healthy children. Eur Neuropsychopharmacol 2010;20(suppl 2):S615-6.
19. Ruta L, Ingudomnukul E, Taylor K, Chakrabati B, Baron-Cohen S. Increased serum androstenedione in adults with autism spectrum conditions. Psychoneuroendocrinology 2011;36:1154-63.
20. Takagishi H, Takahashi T, Yamagishi T, Shinada M, Inukai K, et al. Salivary testosterone levels and autism spectrum quotient in adults. Neuro Endocrinol Lett 2010;31:837-41.
21. Moilanen AM, Karvonen U, Poukka H, Janne OA, Palvimo JJ. Activation of androgen receptor function by a novel nuclear protein kinase. Mol Biol Cell 1998;9:2527-43.
22. Van Honk J, Schutter DJ, Bos PA, Kruijt AW, Lentjes EG, et al. Testosterone administration impairs cognitive empathy in women depending on second-to-fourth digit ratio. Proc Natl Acad Sci USA 2011;108:3448-52.
23. Auyeung B, Baron-Cohen S, Ashwin E, Knickmeyer R, Taylor K, et al. Fetal testosterone and autistic traits. Br J Psychol 2009;100:1-22.
24. Knickmeyer R, Baron-Cohen S, Raggatt P, Taylor K. Fetal testosterone, social relationships, and restricted interests in children. J Child Psychol Psychiatry 2005;46:198-210.
25. Krajmer P, Spajdel M, Kubranska A, Ostatnikova D. 2D:4D finger ratio in Slovak autism spectrum population. Bratisl Lek Listy 2011;112:377-9.
26. Chakrabarti B, Dudbridge F, Kent L, Wheelwright S, Hill-Cawthorne G, et al. Genes related to sex steroids, neural growth, and social-emotional behavior are associated with autistic traits, empathy, and Asperger syndrome. Autism Res 2009;2:157-77.
27. Zhou R, Bird IM, Dumesic DA, Abbott DH. Adrenal hyperandrogenism is induced by fetal androgen excess in a rhesus monkey model of polycystic ovary syndrome. J Clin Endocrinol Metab 2005;90:6630-37.
28. Dorn LD, Hitt SF, Rotenstein D. Biopsychological and cognitive differences in children with premature vs. on-time adrenarche. Arch Pediatr Adolesc Med 1999;153:137-46.
29. Vargas DL, Nascimbene C, Krishnan C, Zimmerman AW, Pardo CA. Neuroglial activation and neuroinflammation in the brain of patients with autism. Ann Neurol 2005;57:67-81.
30. Strous RD, Golubchik P, Maayan R, Mozes T, Tuati-Werner D, et al. Lowered DHEA-S plasma levels in adult individuals with autistic disorders. Eur Neuropsychopharmacol 2005;15:305-9.
31. Tanaka T, Hibi I, Kato K, Saito S, Shimizu N, et al. A dose finding study of a super long-acting luteinizing hormone-releasing hormone analog (leuprolide acetate depot, TAP-144-SR) in the treatment of central precocious puberty. The TAP-144-SR CPP Study Group. Endocrinol Jpn 1991;38:369-76.
32. Bhathena RK. Therapeutic options in the polycystic ovary syndrome. J Obstet Gynaecol 2007;27:123-9.
33. Farquhar C, Lee O, Toomath R, Jepson R. Spironolactone versus placebo or in combination with steroids for hirsutism and/or acne. Cochrane Database Syst Rev 2003;4:CD000194.
34. Zhang X, Zhang Z, Cheng W, Mou X, Reynolds GP. The effect of chronic antipsychotic treatment on sexual behavior, hormones and organ size in the male rat. J Psychopharmacol 2007;21:428-34.
35. Berria R, Gastaldelli A, Lucidi S, Belfort R, De Filippis E, et al. Reduction in hematocrit level after pioglitazone treatment is correlated with decreased plasma free testosterone level, not hemodilution, in women with polycystic ovary syndrome. Clin Pharmacol Ther 2006;80:105-14.